Skip to main content
Erschienen in: Current Heart Failure Reports 3/2018

26.04.2018 | Management of Heart Failure (T. Meyer, Section Editor)

Essential Elements of Early Post Discharge Care of Patients with Heart Failure

Erschienen in: Current Heart Failure Reports | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Heart failure is associated with an enormous burden on both patients and health care systems in the USA. Several national policy initiatives have focused on improving the quality of heart failure care, including reducing readmissions following hospitalization, which are common, costly, and, at least in part, preventable. The transition from inpatient to ambulatory care setting and the immediate post-hospitalization period present an opportunity to further optimize guideline concordant medical therapy, identify reversible issues related to worsening heart failure, and evaluate prognosis. It can also provide opportunities for medication reconciliation and optimization, consideration of device-based therapies, appropriate management of comorbidities, identification of individual barriers to care, and a discussion of goals of care based on prognosis.

Recent Findings

Recent studies suggest that attention to detail regarding patient comorbidities, barriers to care, optimization of both diuretic and neurohormonal therapies, and assessment of prognosis improve patient outcomes. Despite the fact that the transition period appears to be an optimal time to address these issues in a comprehensive manner, most patients are not referred to programs specializing in this approach post hospital discharge.

Summary

The objective of this review is to provide an outline for early post discharge care that allows clinicians and other health care providers to care for these heart failure patients in a manner that is both firmly rooted in the guidelines and patient-centered. Data regarding which intervention is most likely to confer benefit to which subset of patients with this disease is lacking and warrants further study.
Literatur
1.
Zurück zum Zitat Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart disease and stroke Statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135:e146–603.CrossRefPubMedPubMedCentral Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart disease and stroke Statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135:e146–603.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013;6:606–19.CrossRefPubMedPubMedCentral Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013;6:606–19.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Baker H, Oliver-McNeil S, Deng L, Hummel SL. Regional hospital collaboration and outcomes in Medicare heart failure patients: see you in 7. JACC Heart Fail. 2015;3:765–73.CrossRefPubMedPubMedCentral Baker H, Oliver-McNeil S, Deng L, Hummel SL. Regional hospital collaboration and outcomes in Medicare heart failure patients: see you in 7. JACC Heart Fail. 2015;3:765–73.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Ko DT, Alter DA, Austin PC, You JJ, Lee DS, Qiu F, et al. Life expectancy after an index hospitalization for patients with heart failure: a population-based study. Am Heart J. 2008;155:324–31.CrossRefPubMed Ko DT, Alter DA, Austin PC, You JJ, Lee DS, Qiu F, et al. Life expectancy after an index hospitalization for patients with heart failure: a population-based study. Am Heart J. 2008;155:324–31.CrossRefPubMed
6.
Zurück zum Zitat Setoguchi S, Stevenson LW, Schneeweiss S. Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J. 2007;154:260–6.CrossRefPubMed Setoguchi S, Stevenson LW, Schneeweiss S. Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J. 2007;154:260–6.CrossRefPubMed
7.
Zurück zum Zitat Dharmarajan K, Wang Y, Lin Z, Normand SLT, Ross JS, Horwitz LI, et al. Association of changing hospital readmission rates with mortality rates after hospital discharge. JAMA. 2017;318:270–8.CrossRefPubMedPubMedCentral Dharmarajan K, Wang Y, Lin Z, Normand SLT, Ross JS, Horwitz LI, et al. Association of changing hospital readmission rates with mortality rates after hospital discharge. JAMA. 2017;318:270–8.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Krumholz HM, Lin Z, Keenan PS, Chen J, Ross JS, Drye EE, et al. Relationship between hospital readmission and mortality rates for patients hospitalized with acute myocardial infarction, heart failure, or pneumonia. JAMA. 2013;309:587–93.CrossRefPubMedPubMedCentral Krumholz HM, Lin Z, Keenan PS, Chen J, Ross JS, Drye EE, et al. Relationship between hospital readmission and mortality rates for patients hospitalized with acute myocardial infarction, heart failure, or pneumonia. JAMA. 2013;309:587–93.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Srinivasan D, Desai NR. The impact of the transition from volume to value on heart failure care: implications of novel payment models and quality improvement initiatives. J Card Fail. 2017;23:615–20.CrossRefPubMed Srinivasan D, Desai NR. The impact of the transition from volume to value on heart failure care: implications of novel payment models and quality improvement initiatives. J Card Fail. 2017;23:615–20.CrossRefPubMed
10.
Zurück zum Zitat Vidic A, Chibnall JT, Hauptman PJ. Heart failure is a major contributor to hospital readmission penalties. J Card Fail. 2015;21:134–7.CrossRefPubMed Vidic A, Chibnall JT, Hauptman PJ. Heart failure is a major contributor to hospital readmission penalties. J Card Fail. 2015;21:134–7.CrossRefPubMed
11.
Zurück zum Zitat Adams JE. Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I. N Engl J Med. 1994;330:670–4.CrossRefPubMed Adams JE. Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I. N Engl J Med. 1994;330:670–4.CrossRefPubMed
12.
Zurück zum Zitat Donaho EK, Hall AC, Gass JA, Elayda MA, Lee VV, Paire S, et al. Protocol-driven allied health post-discharge transition clinic to reduce hospital readmissions in heart failure. J Am Heart Assoc. 2015;4:e002296.CrossRefPubMedPubMedCentral Donaho EK, Hall AC, Gass JA, Elayda MA, Lee VV, Paire S, et al. Protocol-driven allied health post-discharge transition clinic to reduce hospital readmissions in heart failure. J Am Heart Assoc. 2015;4:e002296.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Hernandez AF, Greiner MA, Fonarow GC, Hammill BG, Heidenreich PA, Yancy CW, et al. Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA. 2010;303:1716–22.CrossRefPubMed Hernandez AF, Greiner MA, Fonarow GC, Hammill BG, Heidenreich PA, Yancy CW, et al. Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA. 2010;303:1716–22.CrossRefPubMed
14.
Zurück zum Zitat Gupta A, Allen LA, Bhatt DL, et al. Association of the hospital readmissions reduction program implementation with readmission and mortality outcomes in heart failure. JAMA Cardiol. 2018;3(1):44–53. Gupta A, Allen LA, Bhatt DL, et al. Association of the hospital readmissions reduction program implementation with readmission and mortality outcomes in heart failure. JAMA Cardiol. 2018;3(1):44–53.
15.
Zurück zum Zitat • Krumholz HM. Post-hospital syndrome—an acquired, transient condition of generalized risk. N Engl J Med. 2013;368(2. This review describes the special circumstances that occur in patients recently discharged from the hospital and calls for a change in the traditional approach to care.):100–2.CrossRefPubMedPubMedCentral • Krumholz HM. Post-hospital syndrome—an acquired, transient condition of generalized risk. N Engl J Med. 2013;368(2. This review describes the special circumstances that occur in patients recently discharged from the hospital and calls for a change in the traditional approach to care.):100–2.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Soufer A, Riello RJ, Desai NR, Testani JM, Ahmad T. A blueprint for the post discharge clinic visit after an admission for heart failure. Prog Cardiovasc Dis. 2017;60:237–48.CrossRefPubMed Soufer A, Riello RJ, Desai NR, Testani JM, Ahmad T. A blueprint for the post discharge clinic visit after an admission for heart failure. Prog Cardiovasc Dis. 2017;60:237–48.CrossRefPubMed
17.
Zurück zum Zitat Dharmarajan K, Hsieh AF, Lin Z, Bueno H, Ross JS, Horwitz LI, et al. Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. JAMA. 2013;309:355–63.CrossRefPubMedPubMedCentral Dharmarajan K, Hsieh AF, Lin Z, Bueno H, Ross JS, Horwitz LI, et al. Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. JAMA. 2013;309:355–63.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat • Albert NM, Barnason S, Deswal A, et al. Transitions of care in heart failure: a scientific statement from the American Heart Association. Circ Heart Fail. 2015;8:384–409. This article discusses strategies for a multi-disciplinary approach to post discharge care. CrossRefPubMed • Albert NM, Barnason S, Deswal A, et al. Transitions of care in heart failure: a scientific statement from the American Heart Association. Circ Heart Fail. 2015;8:384–409. This article discusses strategies for a multi-disciplinary approach to post discharge care. CrossRefPubMed
19.
Zurück zum Zitat Bradley EH, Curry L, Horwitz LI, Sipsma H, Thompson JW, Elma MA, et al. Contemporary evidence about hospital strategies for reducing 30-day readmissions: a national study. J Am Coll Cardiol. 2012;60:607–14.CrossRefPubMedPubMedCentral Bradley EH, Curry L, Horwitz LI, Sipsma H, Thompson JW, Elma MA, et al. Contemporary evidence about hospital strategies for reducing 30-day readmissions: a national study. J Am Coll Cardiol. 2012;60:607–14.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Davis JD, Olsen MA, Bommarito K, et al. All-payer analysis of heart failure hospitalization 30-day readmission: comorbidities matter. Am J Med. 2017;130:93 e9–93 e28.CrossRef Davis JD, Olsen MA, Bommarito K, et al. All-payer analysis of heart failure hospitalization 30-day readmission: comorbidities matter. Am J Med. 2017;130:93 e9–93 e28.CrossRef
21.
Zurück zum Zitat Arora S, Patel P, Lahewala S, Patel N, Patel NJ, Thakore K, et al. Etiologies, trends, and predictors of 30-day readmission in patients with heart failure. Am J Cardiol. 2017;119:760–9.CrossRefPubMed Arora S, Patel P, Lahewala S, Patel N, Patel NJ, Thakore K, et al. Etiologies, trends, and predictors of 30-day readmission in patients with heart failure. Am J Cardiol. 2017;119:760–9.CrossRefPubMed
22.
Zurück zum Zitat Vader JM, LaRue SJ, Stevens SR, et al. Timing and causes of readmission after acute heart failure hospitalization-insights from the heart failure network trials. J Card Fail. 2016;22:875–83.CrossRefPubMedPubMedCentral Vader JM, LaRue SJ, Stevens SR, et al. Timing and causes of readmission after acute heart failure hospitalization-insights from the heart failure network trials. J Card Fail. 2016;22:875–83.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Mentz RJ, Kelly JP, von Lueder TG, Voors AA, Lam CSP, Cowie MR, et al. Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction. J Am Coll Cardiol. 2014;64:2281–93.CrossRefPubMedPubMedCentral Mentz RJ, Kelly JP, von Lueder TG, Voors AA, Lam CSP, Cowie MR, et al. Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction. J Am Coll Cardiol. 2014;64:2281–93.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Link MS. Paradigm shift for treatment of atrial fibrillation in heart failure. N Engl J Med. 2018;378:468–9.CrossRefPubMed Link MS. Paradigm shift for treatment of atrial fibrillation in heart failure. N Engl J Med. 2018;378:468–9.CrossRefPubMed
25.
Zurück zum Zitat O'Connor CM, Whellan DJ, Fiuzat M, et al. Cardiovascular outcomes with minute ventilation-targeted adaptive servo-ventilation therapy in heart failure: The CAT-HF Trial. J Am Coll Cardiol. 2017;69:1577–87.CrossRefPubMed O'Connor CM, Whellan DJ, Fiuzat M, et al. Cardiovascular outcomes with minute ventilation-targeted adaptive servo-ventilation therapy in heart failure: The CAT-HF Trial. J Am Coll Cardiol. 2017;69:1577–87.CrossRefPubMed
26.
Zurück zum Zitat Januzzi JL Jr, Butler J, Jarolim P, Sattar N, Vijapurkar U, Desai M, et al. Effects of canagliflozin on cardiovascular biomarkers in older adults with type 2 diabetes. J Am Coll Cardiol. 2017;70:704–12.CrossRefPubMed Januzzi JL Jr, Butler J, Jarolim P, Sattar N, Vijapurkar U, Desai M, et al. Effects of canagliflozin on cardiovascular biomarkers in older adults with type 2 diabetes. J Am Coll Cardiol. 2017;70:704–12.CrossRefPubMed
27.
Zurück zum Zitat Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009;361:2436–48.CrossRefPubMed Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009;361:2436–48.CrossRefPubMed
28.
Zurück zum Zitat Lewis GD, Malhotra R, Hernandez AF, McNulty SE, Smith A, Felker GM, et al. Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial. JAMA. 2017;317:1958–66.CrossRefPubMedPubMedCentral Lewis GD, Malhotra R, Hernandez AF, McNulty SE, Smith A, Felker GM, et al. Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial. JAMA. 2017;317:1958–66.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Ahmad T, Jackson K, Rao VS, Tang WHW, Brisco-Bacik MA, Chen HH, et al. Worsening renal function in acute heart failure patients undergoing aggressive diuresis is not associated with tubular injury. Circulation AHA. 2018;17.030112(online). Ahmad T, Jackson K, Rao VS, Tang WHW, Brisco-Bacik MA, Chen HH, et al. Worsening renal function in acute heart failure patients undergoing aggressive diuresis is not associated with tubular injury. Circulation AHA. 2018;17.030112(online).
30.
Zurück zum Zitat Ahmad T, Fiuzat M, Felker GM, O'Connor C. Novel biomarkers in chronic heart failure. Nat Rev Cardiol. 2012;9:347–59.CrossRefPubMed Ahmad T, Fiuzat M, Felker GM, O'Connor C. Novel biomarkers in chronic heart failure. Nat Rev Cardiol. 2012;9:347–59.CrossRefPubMed
31.
Zurück zum Zitat Ahmad T, O'Brien EC, Schulte PJ, et al. Evaluation of the incremental prognostic utility of increasingly complex testing in chronic heart failure. Circ Heart Fail. 2015;8:709–16.CrossRefPubMedPubMedCentral Ahmad T, O'Brien EC, Schulte PJ, et al. Evaluation of the incremental prognostic utility of increasingly complex testing in chronic heart failure. Circ Heart Fail. 2015;8:709–16.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Chow SL, Maisel AS, Anand I, et al. Role of biomarkers for the prevention, assessment, and management of heart failure: a scientific statement from the American Heart Association. Circulation. 2017;135:e1054–91.CrossRefPubMed Chow SL, Maisel AS, Anand I, et al. Role of biomarkers for the prevention, assessment, and management of heart failure: a scientific statement from the American Heart Association. Circulation. 2017;135:e1054–91.CrossRefPubMed
33.
Zurück zum Zitat •• Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017;000:e000–e000. https://doi.org/10.1161/CIR.0000000000000509. This comprehensive review outlines state of the art care for patients with heart failure. •• Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017;000:e000–e000. https://​doi.​org/​10.​1161/​CIR.​0000000000000509​. This comprehensive review outlines state of the art care for patients with heart failure.
34.
Zurück zum Zitat Felker GM, Ahmad T, Anstrom KJ, Adams KF, Cooper LS, Ezekowitz JA, et al. Rationale and design of the GUIDE-IT study: guiding evidence based therapy using biomarker intensified treatment in heart failure. JACC Heart Fail. 2014;2:457–65.CrossRefPubMedPubMedCentral Felker GM, Ahmad T, Anstrom KJ, Adams KF, Cooper LS, Ezekowitz JA, et al. Rationale and design of the GUIDE-IT study: guiding evidence based therapy using biomarker intensified treatment in heart failure. JACC Heart Fail. 2014;2:457–65.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Ahmad T, Fiuzat M, Neely B, Neely ML, Pencina MJ, Kraus WE, et al. Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure. JACC Heart Fail. 2014;2:260–8.CrossRefPubMedPubMedCentral Ahmad T, Fiuzat M, Neely B, Neely ML, Pencina MJ, Kraus WE, et al. Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure. JACC Heart Fail. 2014;2:260–8.CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat LaPointe NM, Jollis JG. Medication errors in hospitalized cardiovascular patients. Arch Intern Med. 2003;163:1461–6.CrossRefPubMed LaPointe NM, Jollis JG. Medication errors in hospitalized cardiovascular patients. Arch Intern Med. 2003;163:1461–6.CrossRefPubMed
37.
Zurück zum Zitat Yancy CW, Jessup M, Bozkurt B, et al. ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2016;68:1476–88.CrossRefPubMed Yancy CW, Jessup M, Bozkurt B, et al. ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2016;68:1476–88.CrossRefPubMed
38.
Zurück zum Zitat Yancy CW, Jessup M, Bozkurt B, et al. ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Card Fail. 2017;23(8):628–51. Yancy CW, Jessup M, Bozkurt B, et al. ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Card Fail. 2017;23(8):628–51.
39.
Zurück zum Zitat Yancy CW, Fonarow GC, Albert NM, Curtis AB, Stough WG, Gheorghiade M, et al. Adherence to guideline-recommended adjunctive heart failure therapies among outpatient cardiology practices (findings from IMPROVE HF). Am J Cardiol. 2010;105:255–60.CrossRefPubMed Yancy CW, Fonarow GC, Albert NM, Curtis AB, Stough WG, Gheorghiade M, et al. Adherence to guideline-recommended adjunctive heart failure therapies among outpatient cardiology practices (findings from IMPROVE HF). Am J Cardiol. 2010;105:255–60.CrossRefPubMed
40.
Zurück zum Zitat Chin KL, Skiba M, Tonkin A, Reid CM, Liew D, Krum H, et al. The treatment gap in patients with chronic systolic heart failure: a systematic review of evidence-based prescribing in practice. Heart Fail Rev. 2016;21:675–97.CrossRefPubMed Chin KL, Skiba M, Tonkin A, Reid CM, Liew D, Krum H, et al. The treatment gap in patients with chronic systolic heart failure: a systematic review of evidence-based prescribing in practice. Heart Fail Rev. 2016;21:675–97.CrossRefPubMed
41.
Zurück zum Zitat Felker GM, Anstrom KJ, Adams KF, Ezekowitz JA, Fiuzat M, Houston-Miller N, et al. Effect of natriuretic peptide-guided therapy on hospitalization or cardiovascular mortality in high-risk patients with heart failure and reduced ejection fraction: a randomized clinical trial. JAMA. 2017;318:713–20.CrossRefPubMedPubMedCentral Felker GM, Anstrom KJ, Adams KF, Ezekowitz JA, Fiuzat M, Houston-Miller N, et al. Effect of natriuretic peptide-guided therapy on hospitalization or cardiovascular mortality in high-risk patients with heart failure and reduced ejection fraction: a randomized clinical trial. JAMA. 2017;318:713–20.CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat Ruppar TM, Cooper PS, Mehr DR, Delgado JM, Dunbar-Jacob JM. Medication adherence interventions improve heart failure mortality and readmission rates: systematic review and meta-analysis of controlled trials. J Am Heart Assoc. 2016;5:e002606.CrossRefPubMedPubMedCentral Ruppar TM, Cooper PS, Mehr DR, Delgado JM, Dunbar-Jacob JM. Medication adherence interventions improve heart failure mortality and readmission rates: systematic review and meta-analysis of controlled trials. J Am Heart Assoc. 2016;5:e002606.CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Retrum JH, Boggs J, Hersh A, Wright L, Main DS, Magid DJ, et al. Patient-identified factors related to heart failure readmissions. Circ Cardiovasc Qual Outcomes. 2013;6:171–7.CrossRefPubMedPubMedCentral Retrum JH, Boggs J, Hersh A, Wright L, Main DS, Magid DJ, et al. Patient-identified factors related to heart failure readmissions. Circ Cardiovasc Qual Outcomes. 2013;6:171–7.CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Fraiche AM, Eapen ZJ, McClellan MB. Moving beyond the walls of the clinic: Opportunities and Challenges to the Future of Telehealth in Heart Failure. JACC Heart Fail. 2017;5:297–304.CrossRefPubMed Fraiche AM, Eapen ZJ, McClellan MB. Moving beyond the walls of the clinic: Opportunities and Challenges to the Future of Telehealth in Heart Failure. JACC Heart Fail. 2017;5:297–304.CrossRefPubMed
45.
Zurück zum Zitat Chaudhry SI, Mattera JA, Curtis JP, Spertus JA, Herrin J, Lin Z, et al. Telemonitoring in patients with heart failure. N Engl J Med. 2010;363:2301–9.CrossRefPubMedPubMedCentral Chaudhry SI, Mattera JA, Curtis JP, Spertus JA, Herrin J, Lin Z, et al. Telemonitoring in patients with heart failure. N Engl J Med. 2010;363:2301–9.CrossRefPubMedPubMedCentral
46.
Zurück zum Zitat Morgan JM, Kitt S, Gill J, McComb JM, Ng GA, Raftery J, et al. Remote management of heart failure using implantable electronic devices. Eur Heart J. 2017;38:2352–60.CrossRefPubMedPubMedCentral Morgan JM, Kitt S, Gill J, McComb JM, Ng GA, Raftery J, et al. Remote management of heart failure using implantable electronic devices. Eur Heart J. 2017;38:2352–60.CrossRefPubMedPubMedCentral
47.
Zurück zum Zitat Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011;377:658–66.CrossRefPubMed Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011;377:658–66.CrossRefPubMed
48.
Zurück zum Zitat • Givertz MM, Stevenson LW, Costanzo MR, et al. Pulmonary artery pressure-guided management of patients with heart failure and reduced ejection fraction. J Am Coll Cardiol. 2017;70:1875–86. The authors describe the methods and results of the Champion trial, demonstrating the benefits of pulmonary artery pressure guided therapy in heart failure patients with a history of hospitalization. CrossRefPubMed • Givertz MM, Stevenson LW, Costanzo MR, et al. Pulmonary artery pressure-guided management of patients with heart failure and reduced ejection fraction. J Am Coll Cardiol. 2017;70:1875–86. The authors describe the methods and results of the Champion trial, demonstrating the benefits of pulmonary artery pressure guided therapy in heart failure patients with a history of hospitalization. CrossRefPubMed
49.
Zurück zum Zitat Ponikowski P, Voors AA, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129–200.CrossRefPubMed Ponikowski P, Voors AA, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129–200.CrossRefPubMed
50.
Zurück zum Zitat Yancy CW, Jessup M, Bozkurt B, et al. ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation. 2013;128:e240–e327 Yancy CW, Jessup M, Bozkurt B, et al. ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation. 2013;128:e240–e327
52.
Zurück zum Zitat Russell SD, Miller LW, Pagani FD. Advanced heart failure: a call to action. Congest Heart Fail. 2008;14:316–21.CrossRefPubMed Russell SD, Miller LW, Pagani FD. Advanced heart failure: a call to action. Congest Heart Fail. 2008;14:316–21.CrossRefPubMed
53.
Zurück zum Zitat Ahmad T, Patel CB, Milano CA, Rogers JG. When the heart runs out of heartbeats: treatment options for refractory end-stage heart failure. Circulation. 2012;125:2948–55.CrossRefPubMed Ahmad T, Patel CB, Milano CA, Rogers JG. When the heart runs out of heartbeats: treatment options for refractory end-stage heart failure. Circulation. 2012;125:2948–55.CrossRefPubMed
54.
Zurück zum Zitat Rogers JG, Patel CB, Mentz RJ, Granger BB, Steinhauser KE, Fiuzat M, et al. Palliative care in heart failure: the PAL-HF randomized, controlled clinical trial. J Am Coll Cardiol. 2017;70:331–41.CrossRefPubMed Rogers JG, Patel CB, Mentz RJ, Granger BB, Steinhauser KE, Fiuzat M, et al. Palliative care in heart failure: the PAL-HF randomized, controlled clinical trial. J Am Coll Cardiol. 2017;70:331–41.CrossRefPubMed
55.
Zurück zum Zitat Kheirbek RE, Fletcher RD, Bakitas MA, Fonarow GC, Parvataneni S, Bearden D, et al. Discharge hospice referral and lower 30-day all-cause readmission in Medicare beneficiaries hospitalized for heart failure. Circ Heart Fail. 2015;8:733–40.CrossRefPubMedPubMedCentral Kheirbek RE, Fletcher RD, Bakitas MA, Fonarow GC, Parvataneni S, Bearden D, et al. Discharge hospice referral and lower 30-day all-cause readmission in Medicare beneficiaries hospitalized for heart failure. Circ Heart Fail. 2015;8:733–40.CrossRefPubMedPubMedCentral
Metadaten
Titel
Essential Elements of Early Post Discharge Care of Patients with Heart Failure
Publikationsdatum
26.04.2018
Erschienen in
Current Heart Failure Reports / Ausgabe 3/2018
Print ISSN: 1546-9530
Elektronische ISSN: 1546-9549
DOI
https://doi.org/10.1007/s11897-018-0393-9

Weitere Artikel der Ausgabe 3/2018

Current Heart Failure Reports 3/2018 Zur Ausgabe

Pharmacologic Therapy (W.H.W. Tang, Section Editor)

Management of Sleep Disordered Breathing in Patients with Heart Failure

Pharmacologic Therapy (W.H.W. Tang, Section Editor)

Nutritional Interventions in Heart Failure: Challenges and Opportunities

Pharmacologic Therapy (W.H.W. Tang, Section Editor)

Novel Insights and Treatment Strategies for Right Heart Failure

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.